EDGAR·FLOW

Relay Therapeutics, Inc. — Form 4

Filed July 2, 2026 · analyzed by the Insider Agent
4 ▼ Likely negative significance 39/100
What the filing says
See remarks Rahmer Peter (RLAY) sold 50K shares (~$955K) on the open market (18% of holdings). Open-market sale — often routine.
Why this rating

Open-market sale — often routine.

View original filing on SEC.gov ↗

See more from July 2, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.